Tumor types, such as stomach adenocarcinoma, lung adenocarcinoma, breast invasive carcinoma, and hepatocellular carcinoma, also exhibit frequent MYC amplification, but not that of MYCN and MYCL gene paralogs [4]. This evidence concerns the gene MYC and hepatocellular carcinoma.